CompoAtlas

Golden Gate Yongfert Pill

Golden Gate Yongfert Pill : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
Lycium barbarumLycium barbarum[348.41 mg,3 gm]Not identified
Morinda officinalisMorinda officinalis[104.52 mg,3 gm]Not identified
Cuscuta chinensisCuscuta chinensis[261.31 mg,3 gm]Not identified
Epimedium brevicornumEpimedium brevicornum[130.65 mg,3 gm]Not identified
Curculigo orchioidesCurculigo orchioides[87.1 mg,3 gm]Not identified
Bupleurum chinenseBupleurum chinense[104.52 mg,3 gm]Not identified
Cyperus rotundusCyperus rotundus[104.52 mg,3 gm]Not identified
Angelica sinensisAngelica sinensis[261.31 mg,3 gm]Not identified
Salvia miltiorrhizaSalvia miltiorrhiza[104.52 mg,3 gm]Not identified
Psoralea corylifoliaPsoralea corylifolia[174.21 mg,3 gm]Not identified
Cornus officinalisCornus officinalis[174.21 mg,3 gm]Not identified
Rehmannia glutinosaRehmannia glutinosa[174.21 mg,3 gm]Not identified
Eucommia ulmoidesEucommia ulmoides[261.31 mg,3 gm]Not identified
Polygonatum sibiricumPolygonatum sibiricum[174.21 mg,3 gm]Not identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Product record

Registration number
MAL22026084TC
Type
Natural product
Published status
PRODUCT APPROVED
Licence holder
Golden Gate Fertility Centre Malaysia Sdn. Bhd.
Manufacturer
WHITE HERON PHARMACEUTICAL SDN. BHD.
Registration period starting
2022-02-23
Published validity end
2027-02-23

Original register data

View published fields and their variants
Active ingredients
Lycium barbarum[348.41 mg,3 gm],Morinda officinalis[104.52 mg,3 gm],Cuscuta chinensis[261.31 mg,3 gm],Epimedium brevicornum[130.65 mg,3 gm],Curculigo orchioides[87.1 mg,3 gm],Bupleurum chinense[104.52 mg,3 gm],Cyperus rotundus[104.52 mg,3 gm],Angelica sinensis[261.31 mg,3 gm],Salvia miltiorrhiza[104.52 mg,3 gm],Psoralea corylifolia[174.21 mg,3 gm],Cornus officinalis[174.21 mg,3 gm],Rehmannia glutinosa[174.21 mg,3 gm],Eucommia ulmoides[261.31 mg,3 gm],Polygonatum sibiricum[174.21 mg,3 gm]
Valid until
2027-02-23
Registration date
2022-02-23
Published description
NATURAL PRODUCT
Licence holder
Golden Gate Fertility Centre Malaysia Sdn. Bhd.
Producer
WHITE HERON PHARMACEUTICAL SDN. BHD.
Published name
Golden Gate Yongfert Pill
Published reference
202108255909T
Registration number
MAL22026084TC
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL22026084TC

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Angelica sinensis
    Read the warning, when it applies and the studies cited

    DONG QUAI - ANGELICA SINENSIS

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (NS 2021).

    Sources cited by Health Canada (1)
    • NS 2021: Natural Standard. Dong quai (Angelica sinensis [Oliv.] Diels). [Accessed 2023 December 31]. Available from: https://naturalmedicines.therapeuticresearch.com/databases/food,-herbs-supplements/professional.aspx?productid=936

    Ask a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you are taking any medications including blood thinners, birth control pills or hormone therapy (NS 2021; Brinker 2010; WHO 2002).

    Sources cited by Health Canada (4)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • NS 2021: Natural Standard. Dong quai (Angelica sinensis [Oliv.] Diels). [Accessed 2023 December 31]. Available from: https://naturalmedicines.therapeuticresearch.com/databases/food,-herbs-supplements/professional.aspx?productid=936
    • WHO 2002: World Health Organization Monographs on Selected Medicinal Plants - Volume 2. Geneva (CH): World Health Organization; 2002.
    • OMS 2002: Organisation mondiale de la santé. Monographs on Selected Medicinal Plants - Volume 2. Genève (CH): Organisation mondiale de la santé; 2002.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have serious or major conditions, any type of acute infection, deficiency or excess (HC 2022).

    Sources cited by Health Canada (2)
    • HC 2022: Health Canada. Traditional Chinese Medicine Ingredients monograph. [Accessed 2024 July 10]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=tcm&lang=eng
    • SC 2022: Santé Canada. Monographie sur les Ingrédients de la Médecine Traditionnelle Chinoise. [Consulté le 10 juillet 2024]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=tcm&lang=fre

    When using this product avoid exposure to the sun (NS 2021; Thorne 2004).

    Sources cited by Health Canada (2)
    • NS 2021: Natural Standard. Dong quai (Angelica sinensis [Oliv.] Diels). [Accessed 2023 December 31]. Available from: https://naturalmedicines.therapeuticresearch.com/databases/food,-herbs-supplements/professional.aspx?productid=936
    • Thorne 2004: Thorne Research Inc. Monograph Angelica sinensis (Dong quai). Alternative Medicine Review 2004;9(4):429-433.

    Contraindications

    Do not use if you are pregnant (NS 2021; WHO 2002).

    Sources cited by Health Canada (4)
    • NS 2021: Natural Standard. Dong quai (Angelica sinensis [Oliv.] Diels). [Accessed 2023 December 31]. Available from: https://naturalmedicines.therapeuticresearch.com/databases/food,-herbs-supplements/professional.aspx?productid=936
    • WHO 2002: World Health Organization Monographs on Selected Medicinal Plants - Volume 2. Geneva (CH): World Health Organization; 2002.
    • Brinker F. Herb Contraindications and Drug Interactions, 4e édition. Sandy (OR): Eclectic Medical Publications; 2010.
    • OMS 2002: Organisation mondiale de la santé. Monographs on Selected Medicinal Plants - Volume 2. Genève (CH): Organisation mondiale de la santé; 2002.

    Do not use if you have diarrhea, hemorrhagic diseases or heavy periods (NS 2021, Bensky et al. 2004; Chen and Chen 2004; WHO 2002).

    Sources cited by Health Canada (6)
    • Bensky D, Clavey, Stöger E, Gamble A. Chinese Herbal Medicine: Materia Medica. 3rd edition. Seattle (WA): Eastland Press, Incorporated; 2004.
    • Chen JK, Chen TT. Chinese Medical Herbology and Pharmacology. Crampton L, editor. City of Industry (CA): Art of Medicine Press Inc.; 2004.
    • NS 2021: Natural Standard. Dong quai (Angelica sinensis [Oliv.] Diels). [Accessed 2023 December 31]. Available from: https://naturalmedicines.therapeuticresearch.com/databases/food,-herbs-supplements/professional.aspx?productid=936
    • WHO 2002: World Health Organization Monographs on Selected Medicinal Plants - Volume 2. Geneva (CH): World Health Organization; 2002.
    • Brinker F. Herb Contraindications and Drug Interactions, 4e édition. Sandy (OR): Eclectic Medical Publications; 2010.
    • OMS 2002: Organisation mondiale de la santé. Monographs on Selected Medicinal Plants - Volume 2. Genève (CH): Organisation mondiale de la santé; 2002.

    Known adverse reactions

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen, or if new symptoms develop such as breast pain or any changes in menstrual cycles (Brinker 2010; Schumacher et al. 2007; Thorne 2004; Russell et al. 2002).

    Sources cited by Health Canada (4)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Russell L, Hicks GS, Low AK, Shepherd JM, Brown CA. Phytoestrogens: a viable option? The American Journal of the Medical Sciences 2002;324(4):185-188. PubMed Review article
    • Schumacher M, Guennoun R, Ghoumari A, Massaad C, Robert F, El-Etr M, Akwa Y, Rajkowski K, and Baulieu E. Novel perspectives for progesterone in Hormone Replacement Therapy, with special reference to the nervous system. Endocrine Reviews 2007;28:387-439. PubMed Review article
    • Thorne 2004: Thorne Research Inc. Monograph Angelica sinensis (Dong quai). Alternative Medicine Review 2004;9(4):429-433.

    Health Canada monograph dated 29 May 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Golden Gate Yongfert Pill”, https://compoatlas.com/en/supplements/malaysia/MAL22026084TC-golden-gate-yongfert-pill, updated 27 October 2026.

Enter to analyse, Shift+Enter for a new line